The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII).
Director-Government and Regulatory Affairs at Serum Institute of India (SII) Prakash Kumar Singh had submitted an application to the DCGI on February 21,...
Considering the recommendations made during an SEC meeting on January 31, Dr Reddy's Laboratories presented its proposal for grant of permission to import...
The two-dose vaccine uses adenoviruses that infect chimpanzees to carry the gene responsible for the spike protein of the novel coronavirus.
All the recommendations of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) have been sent to the Drugs Controller...
The submission is based on results of Bharat Biotech's Phase 2/3 paediatric clinical trial involving 526 children between 2-18 years of age.
'The aim is to develop a priority list with the focus being on adolescents aged 12-18 years with comorbidities,' Dr N K Arora said.
The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on...
Previously, India's central drug authority's expert panel sent recommendations for the vaccine's EUA to the Drugs Controller General of India (DCGI) for final...
'On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India,' a Johnson & Johnson India...
Dr Reddy's soft launched the vaccine in India in May 2021, after receiving Emergency Use Authorization (EUA) in April 2021.